Table S2 from Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold
<p>Proteomic_list_Pearson_Q1V-time</p>
Zapisane w:
| 1. autor: | Emmanuel Griessinger (16721087) (author) |
|---|---|
| Kolejni autorzy: | Diego Pereira-Martins (16721090) (author), Marielle Nebout (16721093) (author), Claudie Bosc (16721096) (author), Estelle Saland (16446003) (author), Emiline Boet (16721099) (author), Ambrine Sahal (16446000) (author), Johanna Chiche (16721102) (author), Delphine Debayle (16721105) (author), Lucile Fleuriot (16721108) (author), Maurien Pruis (16721111) (author), Véronique De Mas (16721114) (author), François Vergez (15047358) (author), Christian Récher (15047355) (author), Gerwin Huls (16721117) (author), Jean-Emmanuel Sarry (15112165) (author), Jan Jacob Schuringa (16721120) (author), Jean-François Peyron (16721123) (author) |
| Wydane: |
2025
|
| Hasła przedmiotowe: | |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|
Podobne zapisy
-
Table S1 from Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold
od: Emmanuel Griessinger (16721087)
Wydane: (2025) -
Supplementary Table S1 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
od: Ana Vujovic (15207479)
Wydane: (2025) -
Supplementary Table S2 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
od: Ana Vujovic (15207479)
Wydane: (2025) -
Supplementary Table S3 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
od: Ana Vujovic (15207479)
Wydane: (2025) -
Supplementary Table S4 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
od: Ana Vujovic (15207479)
Wydane: (2025)